Tuesday, 02 January 2024 12:17 GMT

Philip Empey


Date:

(MENAFN- The Conversation)
  • Associate Professor, University of Pittsburgh School of Pharmacy, University of Pittsburgh
Profile Articles

Dr. Philip Empey is the Associate Director for Pharmacogenomics of the Pitt/UPMC Institute for Precision Medicine and leads the PreCISE-Rx and Test2Learn teams to implement pharmacogenomics clinical, research, and educational initiatives. He also directs the Pharamcogenomics Center of Excellence which is deploying population scale preemptive pharmagenomics testing (to >150,000 patients) in western Pennsylvania. As a clinician-scientist in the Department of Pharmacy and Therapeutics, Dr. Empey conducts NIH-funded clinical and translational research aimed at understanding the mechanisms of the variability in drug response to improve medication-related outcomes in critically-ill patients.

He received his PharmD from the University of Rhode Island and completed PGY1 and PGY2 residencies in Pharmacy Practice and Critical Care at the University of Kentucky. He earned a PhD in Clinical Pharmaceutical Sciences at the University of Kentucky before completing postdoctoral research training at the University of Pittsburgh.

Experience
  • 2009–present Associate Professor, Pharmacy & Therapeutics, University of Pittsburgh

The Conversation

MENAFN11112026000199003603ID1111949180


The Conversation

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search